129 related articles for article (PubMed ID: 37163946)
1. Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase.
Fu T; Zuo Y; Xue G; Zhou D; Pan Z
Eur J Med Chem; 2023 Aug; 256():115460. PubMed ID: 37163946
[TBL] [Abstract][Full Text] [Related]
2. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK).
Fu T; Zuo Y; Zhong Z; Chen X; Pan Z
Eur J Med Chem; 2022 Feb; 229():114051. PubMed ID: 34952433
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
Fallacara AL; Passannanti R; Mori M; Iovenitti G; Musumeci F; Greco C; Crespan E; Kissova M; Maga G; Tarantelli C; Spriano F; Gaudio E; Bertoni F; Botta M; Schenone S
Eur J Med Chem; 2019 Nov; 181():111545. PubMed ID: 31400706
[TBL] [Abstract][Full Text] [Related]
5. A novel BLK-induced tumor model.
Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
[TBL] [Abstract][Full Text] [Related]
6. Expression of protein tyrosine kinases in the Ig complex of anti-mu-sensitive and anti-mu-resistant B-cell lymphomas: role of the p55blk kinase in signaling growth arrest and apoptosis.
Yao XR; Scott DW
Immunol Rev; 1993 Apr; 132():163-86. PubMed ID: 8349295
[TBL] [Abstract][Full Text] [Related]
7. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
Dymecki SM; Niederhuber JE; Desiderio SV
Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.
Yao XR; Scott DW
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of the B cell antigen receptor signaling components in COS cells.
Saouaf SJ; Kut SA; Fargnoli J; Rowley RB; Bolen JB; Mahajan S
J Biol Chem; 1995 Nov; 270(45):27072-8. PubMed ID: 7592958
[TBL] [Abstract][Full Text] [Related]
11. Kinase-independent potentiation of B cell antigen receptor-mediated signal transduction by the protein tyrosine kinase Src.
Lin J; Tao J; Dyer RB; Herzog NK; Justement LB
J Immunol; 1997 Nov; 159(10):4823-33. PubMed ID: 9366407
[TBL] [Abstract][Full Text] [Related]
12. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes.
Malek SN; Desiderio S
J Biol Chem; 1993 Oct; 268(30):22557-65. PubMed ID: 8226767
[TBL] [Abstract][Full Text] [Related]
13. Activation of syk in an immature B cell line does not require lyn activity.
Muthukkumar S; Venkataraman C; Woods T; Bondada S
Mol Immunol; 1997; 34(12-13):865-75. PubMed ID: 9464522
[TBL] [Abstract][Full Text] [Related]
14. The SH2 domains of Src family kinases associate with Syk.
Aoki Y; Kim YT; Stillwell R; Kim TJ; Pillai S
J Biol Chem; 1995 Jun; 270(26):15658-63. PubMed ID: 7797565
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
[TBL] [Abstract][Full Text] [Related]
16. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
Tretter T; Ross AE; Dordai DI; Desiderio S
J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
[TBL] [Abstract][Full Text] [Related]
17. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.
Zwollo P; Desiderio S
J Biol Chem; 1994 May; 269(21):15310-7. PubMed ID: 8195169
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.
Aoki Y; Isselbacher KJ; Cherayil BJ; Pillai S
Proc Natl Acad Sci U S A; 1994 May; 91(10):4204-8. PubMed ID: 7514299
[TBL] [Abstract][Full Text] [Related]
19. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk.
Dymecki SM; Zwollo P; Zeller K; Kuhajda FP; Desiderio SV
J Biol Chem; 1992 Mar; 267(7):4815-23. PubMed ID: 1537861
[TBL] [Abstract][Full Text] [Related]
20. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
